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CARDIOVASCULAR RISK IN CHILDREN
Don’t rush into testing and treating children
Jennifer Logue senior clinical lecturer in metabolic medicine, Naveed Sattar professor of medicine
University of Glasgow, BHF Cardiovascular Research Centre, Glasgow G12 8TA, UK
Although Friedemann and colleagues’ meta-analysis confirmed
that obesity worsens risk factors for cardiovascular disease in
children,1 we do not entirely agree with their recommendations.
The authors mention targeting risk factors before they reach
abnormal limits and defining cut offs for risk as a guide to
treatment. This implies a link between obesity related
cardiovascular risk factors in childhood, attenuation of these
risk factors, and clinical benefit above current practice for adult
cardiovascular disease, which has not been proved. The
suggestion of performing blood tests and treating children and
adolescents is premature because evidence of benefit is lacking
and there are potential risks in a growing child.2 Given that the
obesity epidemic is the reason for interest in these risk factors
in children, and obesity increases the likelihood of unfavourable
risk factors, surely we should be preventing, monitoring, and
treating obesity itself in this age group. Normalisation of body
mass would have many health benefits beyond cardiovascular
risk factors.
In addition, an overweight or obese child will not necessarily
become an overweight or obese adolescent with abnormal
cardiovascular risk factors. One study found that more than 45%
of children classified as overweight or obese at age 9-12 years
were normal weight by 15-16 years. These children had more
favourable cardiovascular risk factors than those who remained
overweight or obese, and in the case of girls, equivalent to those
who were persistently normal weight.3 This highlights the
complexity of childhood obesity and why it is unwise to
recommend blood tests and treatments that have no evidence
base for improved outcomes. Recommending participation in
a family based intervention to improve diet (and increase
activity) would fulfil the pledge to “first do no harm.”
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